Translations:Glucagon-like peptide-1/22/en: Difference between revisions
Jump to navigation
Jump to search
Importing a new version from external source |
(No difference)
|
Latest revision as of 09:48, 11 March 2024
In the stomach, GLP-1 inhibits gastric emptying, acid secretion and motility, which collectively decrease appetite. By decelerating gastric emptying GLP-1 reduces postprandial glucose excursion which is another attractive property regarding diabetes treatment. However, these gastrointestinal activities are also the reason why subjects treated with GLP-1-based agents occasionally experience nausea.